Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Allan Weber"'
Autor:
Allan Weber, Jinsong Ni, Kah-Hiing John Ling, Andrew Acheampong, Diane D-S. Tang-Liu, Robert Burk, Benjamin F. Cravatt, David Woodward
Publikováno v:
Journal of Lipid Research, Vol 45, Iss 4, Pp 757-763 (2004)
We investigated the formation of PGF2α 1-ethanolamide, PGE2 1-ethanolamide, and PGD2 1-ethanolamide (prostamides F2α, E2, and D2, respectively) in liver, lung, kidney, and small intestine after a single intravenous bolus administration of 50 mg/kg
Externí odkaz:
https://doaj.org/article/dd23b20e2bfb4e229670a1694a0b90e7
Autor:
Arnold L. Smith, Allan Weber, Kevin L. Nelson, William C. T. Unrath, William N. Howald, Toni Kline, Alice L. Erwin
Publikováno v:
Antimicrobial Agents and Chemotherapy. 51:2820-2829
The p -nitroaromatic antibiotic chloramphenicol has been used extensively to treat life-threatening infections due to Haemophilus influenzae and Neisseria meningitidis ; its mechanism of action is the inhibition of protein synthesis. We found that du
Publikováno v:
The Journal of Infectious Diseases. 183:919-927
Pulmonary infection with Pseudomonas aeruginosa in patients with cystic fibrosis (CF) causes a chronic destructive bronchitis. A xenograft model was used to study the susceptibility of the CF respiratory epithelium to P. aeruginosa strain PAK and the
Autor:
Arnold L. Smith, Allan Weber, Mindy Kaplan, Leah A. Cohn, Jashvant D. Unadkat, Shazia A. Chughtai
Publikováno v:
Biopharmaceutics & Drug Disposition. 22:157-168
Rifabutin is effective in the treatment and prevention of Mycobacterium avium infection in people with HIV infection. Rifabutin is structurally related to another rifamycin, rifampin, a well-known inducer of the human P-450 isoform 3A. The rabbit iso
Autor:
Rik C. Schoemaker, Bert J. van der Heijden, Herman J. Neijens, John N. van den Anker, Ronald de Groot, Allan Weber, Pieter J J Sauer, W. C. J. Hop
Publikováno v:
Clinical Pharmacology & Therapeutics. 58:650-659
Objective: The objectives of this study were (1) to determine the effects of gestational age on ceftmidlme pharmacoklnetics in the preterm infant, (2) to relate these effects to changes in glomerular filtration rate (GFR), and (3) to establish approp
Publikováno v:
American Journal of Therapeutics. 2:81-87
We sought to describe tobramycin absorption after aerosol administration to cystic fibrosis (CF) subjects. Serum tobramycin concentrations were determined by modification of the radioimmuno-assay (RIA) technique, lowering the limit of detection from
Publikováno v:
Developmental Pharmacology and Therapeutics. 16:7-12
Probenecid pharmacokinetics were studied in 5 cystic fibrosis (CF) subjects and 5 control subjects at oral dosages of 5, 15, and 30 mg/kg. Serum and urine samples were collected for 8 h after administration and assayed by reverse phase high performan
Autor:
Carolyn Ann Meeks, Allan Weber, Kent E. Opheim, Jeffrey R. Koup, Arnold L. Smith, C.T. Vishwanathan
Publikováno v:
Developmental Pharmacology and Therapeutics. 14:35-44
We determined the apparent bioavailability of dicloxacillin in 26 children between the ages of 0.24 and 143 months by comparing the area under the serum concentration versus time curve following intravenous and oral administration of 25 mg/kg. With i
Publikováno v:
The Journal of pediatrics. 142(1)
Objectives To determine if patients with cystic fibrosis (CF) have an altered pharmacokinetic profile of montelukast, we studied the single-dose pharmacokinetics in 12 patients with CF and 12 age- and gender-matched controls after they received a 10-
Haemophilus influenzae, especially the nontypeable strains, are among the most common pathogens encountered in patients with chronic lung disease and otitis media. We and others have demonstrated that respiratory isolates of nontypeableH. influenzaeb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1639a87ecbaf58ff914bf030e27c2ad7
https://europepmc.org/articles/PMC97602/
https://europepmc.org/articles/PMC97602/